Keywords: astrazeneca, buys, back, shares, anglo-swedish, drug, major
AstraZeneca buys back 500,000 shares
Article | 10 November 2003
Anglo-Swedish drug major AstraZeneca says that it repurchased 500,000of its own shares for cancellation on October 30. The London-headquartered firm's stock ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
